- Home
- PBYI vs SIEB Comparison
PBYI vs SIEB Comparison
Compare PBYI & SIEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- SIEB
- Stock Information
- Founded
- PBYI 2010
- SIEB 1886
- Country
- PBYI United States
- SIEB United States
- Employees
- PBYI N/A
- SIEB N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- SIEB Investment Bankers/Brokers/Service
- Sector
- PBYI Health Care
- SIEB Finance
- Exchange
- PBYI Nasdaq
- SIEB Nasdaq
- Market Cap
- PBYI 164.3M
- SIEB 148.8M
- IPO Year
- PBYI N/A
- SIEB N/A
- Fundamental
- Price
- PBYI $3.54
- SIEB $4.75
- Analyst Decision
- PBYI Strong Buy
- SIEB
- Analyst Count
- PBYI 1
- SIEB 0
- Target Price
- PBYI $7.00
- SIEB N/A
- AVG Volume (30 Days)
- PBYI 306.9K
- SIEB 233.2K
- Earning Date
- PBYI 07-31-2025
- SIEB 08-13-2025
- Dividend Yield
- PBYI N/A
- SIEB N/A
- EPS Growth
- PBYI 143.51
- SIEB 117.05
- EPS
- PBYI 0.77
- SIEB 0.46
- Revenue
- PBYI $232,709,000.00
- SIEB $92,064,000.00
- Revenue This Year
- PBYI N/A
- SIEB N/A
- Revenue Next Year
- PBYI N/A
- SIEB N/A
- P/E Ratio
- PBYI $4.64
- SIEB $10.42
- Revenue Growth
- PBYI 2.68
- SIEB 21.82
- 52 Week Low
- PBYI $2.23
- SIEB $1.41
- 52 Week High
- PBYI $4.13
- SIEB $5.77
- Technical
- Relative Strength Index (RSI)
- PBYI 58.61
- SIEB 53.21
- Support Level
- PBYI $3.26
- SIEB $4.18
- Resistance Level
- PBYI $3.65
- SIEB $4.87
- Average True Range (ATR)
- PBYI 0.14
- SIEB 0.36
- MACD
- PBYI 0.01
- SIEB -0.03
- Stochastic Oscillator
- PBYI 84.78
- SIEB 75.00
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About SIEB Siebert Financial Corp.
Siebert Financial Corp is a diversified financial services firm and provides a full range of brokerage and financial advisory services including securities brokerage, investment advisory and insurance offerings, and corporate stock plan administration solutions. The firm mainly provides online and traditional brokerage and related services to retail investors and also acts as an investment advisor for its subsidiary. The company operates in the securities brokerage and asset management industry. It also engages in Insurance services, Robo-advisory technology, and Prime brokerage business through its subsidiaries.